Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Decisions and Verdicts, Drugs (Pharmaceuticals), Federal-State Relations (US), Food and Drug Administration, mifepristone, Regulation and Deregulation of Industry, Suits and Litigation (Civil), Supreme Court (US)
←‘Succession’ Fans Flip Out After Major Character’s Death Changes Everything [SPOILERS]
A.I. Is Coming for Lawyers, Again→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube